Albany, New York (PRWEB) April 30, 2013
According to WHO, more than 190 million patients suffering from chronic renal failure undergo renal dialysis. Rising incidence of hypertension is another key factor responsible for the increase in renal failure around the world. Benign prostatic hyperplasia is an occurrence that is common among the aging population. Over 220 million males suffer from a swelling of the prostate glands as of 2012, which results in a blockage of the flow of urine through the body.
Related Report : mHealth Market
This blockage can cause bladder damage, and increase the likelihood of urinary infection in males, which may lead to severe impairment of the life of the patient. According to Kidney Health Alliance, 250,000 people in Europe are being treated by kidney dialysis every year. The dialysis equipment market represented the largest segment, accounting for over 74% of the total market, followed by devices used for treating kidney and bladder stones.
Related Report : Implantable Medical Devices Market
Europe was estimated to be the largest market in the nephrology & urology devices market. The region accounted for a market share of over 33%, followed by North America. Europe led the key markets of dialysis and sacral neurostimulation; however, North America is expected to expand its sacral neurostimulation market in the coming years, and nibble into Europe's share. Asia Pacific is expected to be placed third, followed by the Rest of the World region.Emerging markets such as Asia Pacific and the Middle East are highly price sensitive.
Related Report : Interventional Cardiology Devices Market
Due to low healthcare treatment costs and lower income levels, physicians and healthcare organizations hesitate to invest in expensive devices such as lithotripters and dialysis equipment. Nevertheless, in the last decade, it was observed that many healthcare providers adopted advanced technologies in order to satisfy the needs of the growing patient base while maintaining their budget limits. Thus, manufacturers hold great opportunity in these markets by developing economical solutions in the coming years.
Browse the full report with TOC at http://www.transparencymarketresearch.com/nephrology-and-urology-devices-market.html
The dialysis market, being the largest fraction of the nephrology & urology devices market, is responsible for the majority of key players. In 2011, Fresenius was the leading player in the market, followed by Gambro, which was acquired in 2012-2013 by Baxter. Baxter is expected to lead the market in the coming years. The market is highly fragmented, and a few other players in the industry include Nikkiso, Nipro, Medtronic (neurostimulation), Dornier Medtech, Cook Medical, and EDAP TMS.
Browse all market research reports: http://www.transparencymarketresearch.com/